Identifies potential investment opportunities within the life sciences sector. Evaluates the financial and scientific merits of life science assets. Now — the numbers.
An investor who bought at the very peak is down 98% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Our checks did not surface a specific strength to highlight here.
The stock sits at $0.0008. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
This stock swings about 3.2 times as much as the market average. Big rallies — and big drops — can both happen fast.
At last year’s rate of cash burn, the cash lasts less than a year. After that, the company needs to find new money.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: revenue and profit, the growth trend, the revenue breakdown.